Quantcast

Elsevier, EMBL and University of Copenhagen Launch New App for SciVerse

April 13, 2011

AMSTERDAM, April 13, 2011 /PRNewswire-FirstCall/ –

– Reflect-Network Application Visualizes Interactions Between Molecular
Biological Entities

Elsevier, a world leading publisher of scientific, technical and medical
information products and services, today announced the availability of a new
application, Reflect-Network, on SciVerse Applications beta. The application
was developed in partnership with the European Molecular Biology Laboratory
(EMBL), Germany, and the Novo Nordisk Foundation Center for Protein Research
(CPR), University of Copenhagen, Denmark.

The Reflect-Network application is integrated within the life sciences
journals on SciVerse Science Direct via Reflect, a tool that tags proteins
and chemicals in a document. The application recognizes genes, proteins, and
chemicals mentioned within SciVerse ScienceDirect articles, and generates a
graphical representation displaying the interactions or ‘network’ between the
entities. From the graphic, researchers can then link to the STITCH network,
which provides additional details about the entities and offers different
ways to view the ‘network’ such as color-coded lines revealing modes of
action, or drilling down to examine the evidence supporting each interaction.

“For researchers working in the life sciences, as in other areas, a major
challenge is sifting through an extraordinary amount of information,” says Dr

Sean O’ Donoghue, Research Scientist at EMBL. “Our goal while developing this
application was to provide data in a clear and concise way for researchers to
quickly understand relationships among molecular biological entities within
an article.”

“Today’s web-based tools help researchers get a better overview of the
existing scientific knowledge. By integrating two such tools – Reflect and
STITCH – with scientific literature, we aim to make both the tools and the
literature more useful to researchers,” says Lars Juhl Jensen, Professor and
Group Leader at CPR.

“The Reflect-Network application within SciVerse Applications and
SciVerse ScienceDirect addresses the workflow challenges of life sciences
researchers by helping them quickly understand and visualize the content of
an article,” said Rafael Sidi, Vice President, SciVerse Applications and
Developer Network at Elsevier. “We continue to collaborate with organizations
like EMBL and CPR to advance the scientific search and discovery process.”

EMBL and CPR won first prize during the 2009 Elsevier Grand Challenge for
Reflect, the application that powers the Reflect-Network Application.

About The European Molecular Biology Laboratory

The European Molecular Biology Laboratory is a basic research institute
funded by public research monies from 20 member states (Austria, Belgium,
Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel,
Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden,
Switzerland and the United Kingdom) and associate member state Australia.
Research at EMBL is conducted by approximately 85 independent groups covering
the spectrum of molecular biology. The Laboratory has five units: the main
Laboratory in Heidelberg, and Outstations in Hinxton (the European
Bioinformatics Institute), Grenoble, Hamburg, and Monterotondo near Rome.

The cornerstones of EMBL’s mission are: to perform basic research in
molecular biology; to train scientists, students and visitors at all levels;
to offer vital services to scientists in the member states; to develop new
instruments and methods in the life sciences and to actively engage in
technology transfer activities. Around 190 students are enrolled in EMBL’s
International PhD programme. Additionally, the Laboratory offers a platform
for dialogue with the general public through various science communication
activities such as lecture series, visitor programmes and the dissemination
of scientific achievements.

About The Novo Nordisk Foundation Center for Protein Research

The Novo Nordisk Foundation Center for Protein Research at the Faculty of
Health Sciences, University of Copenhagen, has been established to promote
basic and applied discovery research on human proteins of medical relevance;
with the explicit goal of being among the leading laboratories within our
focus areas. The Center operates from a significant donation from the Novo
Nordisk Foundation as well as other external funding sources. In addition,
the University of Copenhagen has made major contributions towards the
building of the new Center laboratories which were opened during 2009. The
Center operates as an integral part of the Faculty of Health Sciences,
University of Copenhagen and has secured world-class capabilities in a number
of protein-focused research areas and disciplines.

The Center has a wide range of expertise and resources in protein
production, chemical biology, disease systems biology and mass
spectrometry-based proteomics as well as having dedicated research groups
focused on ubiquitin modified signalling and molecular endocrinology. We are
also prioritizing translational research opportunities in medicine with the
aim of generating research results that are useful for facilitating drug
discovery and development.

About the Elsevier SciVerse Suite

The SciVerse (http://www.sciverse.com) suite of search and discovery
offerings provides the global research community access to a constantly
expanding universe of content and solutions which can now be accessed in one
platform. The suite currently includes SciVerse ScienceDirect (
http://www.sciencedirect.com), the world’s largest source of peer-reviewed
content containing more than 10 million articles, and SciVerse Scopus
(http://www.scopus.com), an abstract and citation database containing 41
million records, 70% with abstracts and nearly 18,000 titles from 5,000
publishers worldwide. The new platform also includes SciVerse Hub beta
(http://www.hub.sciverse.com), which enables researchers to perform a single
search across all of the SciVerse content as well as targeted web content
with results ranked by relevancy and without duplication. SciVerse
Applications beta (http://www.applications.sciverse.com), a new module within
the suite, is a marketplace and developer network that allows the scientific
community to build, find and use applications that enhance the SciVerse
research experience.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (http://www.thelancet.com/) and Cell (
http://www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus
(http://www.scopus.nl/), Reaxys (https://www.reaxys.com/), MD Consult
(http://www.mdconsult.com/) and Nursing Consult (
http://www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (http://www.scival.com/) and
MEDai’s Pinpoint Review (http://www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (http://www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Jen Saunders/Sandra Plasse
    +1-212-752-8338
    splasse@psbpr.com
    jsaunders@psbpr.com

SOURCE Elsevier


Source: newswire



comments powered by Disqus